BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18388242)

  • 1. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
    Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
    Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.
    Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
    Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
    Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB1 receptors regulate salivation.
    Andreis K; Billingsley J; Naimi Shirazi K; Wager-Miller J; Johnson C; Bradshaw H; Straiker A
    Sci Rep; 2022 Aug; 12(1):14182. PubMed ID: 35986066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
    Pertwee RG
    Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
    Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
    Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
    Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids as novel anti-inflammatory drugs.
    Nagarkatti P; Pandey R; Rieder SA; Hegde VL; Nagarkatti M
    Future Med Chem; 2009 Oct; 1(7):1333-49. PubMed ID: 20191092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R; Huffman JW; Martin ZL; Welch SP
    J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.
    Walentiny DM; Gamage TF; Warner JA; Nguyen TK; Grainger DB; Wiley JL; Vann RE
    Eur J Pharmacol; 2011 Apr; 656(1-3):63-7. PubMed ID: 21300050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.